Deanol in the treatment of levodopa-induced dyskinesias.
D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003642:Deanol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008409:Mastication; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*
D000928:Antidepressive Agents; D004983:Ethanolamines; D003642:Deanol; D004295:Dihydroxyphenylalanine